IP Library Granted Patent US 10,864,334
Granted Patent B2
US 10,864,334 · App. 15/924,536 · Granted Dec 15, 2020

Nasal delivery

Inventor: Per Gisle Djupesland (Oslo, NO)
Assignee: OptiNose AS
A61M15/08A61M11/00A61M15/0003A61M15/009A61M15/0021A61M15/0098A61M15/0065A61M2202/04A61M2202/064A61M2205/075A61M2210/0618A61M2210/0625
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,864,334
App. No.
15/924,536
Granted
Dec 15, 2020
Kind
B2
Abstract

A delivery device for and method of delivering a dose of substance for systemic uptake to a nasal cavity of a subject. The delivery device includes a nosepiece unit for insertion into a nasal cavity of a subject and an outlet unit which includes at least one nozzle for delivering substance for systemic uptake substantially only to surfaces in one or both of the anterior region and an anterior section of the posterior region of the nasal cavity of the subject. The delivery device also includes a substance supply unit which is operable to deliver a dose of substance to the at least one nozzle.

Claims (33)

1. A substance delivery device for delivering a first substance and a second substance to a nasal cavity of a subject for systemic uptake, the delivery device comprising:

a nosepiece for insertion into the nasal cavity of the subject, the nosepiece including an outlet unit comprising:

a first nozzle for delivering the first substance;

a second nozzle for delivering the second substance; and

a posterior nosepiece member configured to obstruct the nasal cavity and partition the nasal cavity into an anterior region and a posterior region, such that the first substance is delivered from the first nozzle to surfaces only in the anterior region and the second substance is delivered from the second nozzle to surfaces only in an anterior portion of the posterior region; and

a substance supply unit configured to deliver the first substance to the first nozzle and the second substance to the second nozzle.

2. The delivery device of claim 1 , wherein the substance supply unit is breath actuated on exhalation by the subject.

3. The delivery device of claim 1 , wherein the substance supply unit is breath actuated on nasal exhalation by the subject.

4. The delivery device of claim 1 , wherein the substance supply unit is manually actuated.

5. The delivery device of claim 1 , wherein the outlet unit comprises two first nozzles, each of the two first nozzles being arranged so as to direct the first substance to a lateral surface within the anterior region of the nasal cavity.

6. The delivery device of claim 1 , wherein the first nozzle is substantially laterally directed so as to direct the first substance to a lateral surface within the anterior region of the nasal cavity.

7. The delivery device of claim 1 , wherein the first nozzle is configured to deliver a liquid.

8. The delivery device of claim 1 , wherein the first nozzle is configured to deliver a powder.

9. The delivery device of claim 1 , wherein the posterior region comprises the region of the nasal cavity posterior of the nasal valve.

10. The delivery device of claim 1 , wherein the posterior nosepiece member is configured to close the nasal valve of the subject.

11. The delivery device of claim 1 , further comprising:

a mouthpiece through which the subject exhales to cause closure of an oropharyngeal velum of the subject.

12. The delivery device of claim 1 , wherein the second nozzle is substantially laterally directed so as to direct the second substance to a lateral surface within the anterior portion of the posterior region of the nasal cavity.

13. A method of delivering a first substance and a second substance to a nasal cavity of a subject for systemic uptake, the method comprising:

inserting a nosepiece into the nasal cavity of the subject, the nosepiece including an outlet unit having:

a first nozzle for delivering the first substance,

a second nozzle for delivering the second substance, and

a posterior nosepiece member configured to obstruct the nasal cavity and partition the nasal cavity into an anterior region and a posterior region;

causing the first substance to be delivered from the first nozzle to surfaces in the anterior region; and

causing the second substance to be delivered from the second nozzle to surfaces in an anterior portion of the posterior region.

14. The method of claim 13 , wherein the first nozzle is substantially laterally directed so as to direct the first substance to a lateral surface within the anterior region of the nasal cavity.

15. The method of claim 13 , wherein the first nozzle is configured to deliver a liquid.

16. The method of claim 13 , wherein the first nozzle is configured to deliver a powder.

17. The method of claim 13 , wherein the posterior region comprises the region of the nasal cavity posterior of the nasal valve.

18. The method of claim 13 , wherein the posterior nosepiece member is configured to close the nasal valve of the subject.

19. The method of claim 13 , further comprising:

inserting a mouthpiece into a mouth of the subject through which the subject exhales to cause closure of an oropharyngeal velum of the subject.

20. The method of claim 13 , wherein the second nozzle is substantially laterally directed so as to direct the second substance to a lateral surface within the anterior portion of the posterior region of the nasal cavity.

Assignments (8)
RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL/FRAME 71337/0132 Recorded Mar 17, 2026
From: OAKTREE FUND ADMINISTRATION, LLC
To: OPTINOSE, INC.
Reel/Frame 075101/0804 →
PATENT SECURITY AGREEMENT Recorded Mar 16, 2026
From: OPTINOSE, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 075111/0018 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2025
From: DJUPESLAND, PER GISLE
To: OPTINOSE AS
Reel/Frame 072270/0639 →
SECURITY INTEREST Recorded May 22, 2025
From: OPTINOSE, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 071337/0132 →
RELEASE OF SECURITY INTEREST Recorded May 21, 2025
From: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
To: OPTINOSE INC.
Reel/Frame 071547/0979 →
CHANGE OF ADDRESS Recorded Jan 8, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069846/0939 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2022
From: OPTINOSE AS
To: OPTINOSE INC
Reel/Frame 061546/0424 →
SECURITY INTEREST Recorded Sep 13, 2019
From: OPTINOSE AS
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 050371/0913 →
Cited By (1)
US 12,364,831